He’s done a lot for mainstream interest in gerontology and longevity research but it’s pretty clear at this point that he’s financially tied to his position, there are multiple companies worth millions that develop…
He’s done a lot for mainstream interest in gerontology and longevity research but it’s pretty clear at this point that he’s financially tied to his position, there are multiple companies worth millions that develop…